MoonLake Immunotherapeutics Class A
NASDAQ · Common stock
Close, Oct 20, 2026
Context across dimensions, not a rating
Counts ending at the latest intermediate swing high, 62.75 on Sep 26, 2025. 214 labelings tested, 179 broke a hard rule, 12+ remain.
No price band within 35% of the close has two or more independent Fibonacci relationships.
Intermediate degree · from the preferred count
No scenario at intermediate degree right now
The count has no unreached Fibonacci target beyond the current price. Viridia shows nothing rather than a guess.
Daily chart, as of Oct 20, 2026
Since the count's last pivot (62.75, Sep 26, 2025) price has moved −83.6%, the way the count expects.12 of 12 rule-valid counts expect the current move to be down.Weekly count: flat wave C ↓, same direction
A three-wave zigzag correction up looks complete, so the larger trend would normally resume down.
A-B-C from 31.42, Apr 9, 2025
6 of 6 checks met
The pattern ended here. A move above it means its last wave is still going, so the pattern isn't complete.
No unreached Fibonacci target.
No zone within 35% of price.
A five-wave advance (ending diagonal) looks complete, so a correction down would normally follow.
1-2-3-4-5 from 31.42, Apr 9, 2025
3 of 3 checks met
None.
No structural events recorded yet. Events compare each analysed session with the previous one.
Wave counts are built on these swings and each one passes every rule in the rulebook. They are ranked by how many guidelines they satisfy; the preferred and alternate counts are summarized above the chart.